We are live on ! Find out more
UBS Group

UBS Group Portfolio holdings

AUM $666B
1-Year Est. Return 30.12%
 

UBS Group AG, formed through the 1998 merger of Union Bank of Switzerland and Swiss Bank Corporation with roots dating back to 1862, is a Swiss multinational investment bank and financial services firm headquartered in Zurich. Renowned for its dominance in wealth management, UBS serves high-net-worth individuals and families globally, managing trillions in assets, while also offering investment banking, asset management, and retail banking services in Switzerland. The firm has weathered significant challenges, including a major bailout during the 2008 financial crisis, but has since refocused on stability and sustainable growth, emphasizing digital transformation and ESG (environmental, social, governance) investing. With a strong European base and a global reach, UBS remains a cornerstone of the international financial landscape.

This Fund
S&P 500
This Quarter Est. Return
+8.15%
1 Year Est. Return
+30.12%
3 Year Est. Return
+86.21%
5 Year Est. Return
+101.56%
10 Year Est. Return
+367.78%
AUM
$287B
AUM Growth
+$27.6B
Cap. Flow
+$6.59B
Cap. Flow %
2.29%
Top 10 Hldgs %
12.98%
Holding
8,864
New
808
Increased
4,306
Reduced
2,684
Closed
688

Sector Composition

Rank Sector Weight
1 Technology 9.82%
2 Financials 7.38%
3 Healthcare 6.65%
4 Consumer Discretionary 5.46%
5 Industrials 5.17%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
ATNM icon
6501
Actinium Pharmaceuticals
ATNM
$25M
$38K ﹤0.01%
5,833
+3,178
+120% +$21.9K
DCH
6502
Dauch Corp
DCH
$1.51B
$38K ﹤0.01%
3,528
+981
+39% +$9.34K
BIB icon
6503
ProShares Ultra NASDAQ Biotechnology
BIB
$86.2M
$38K ﹤0.01%
616
-987
-62% -$52.7K
EEMO icon
6504
Invesco S&P Emerging Markets Momentum ETF
EEMO
$24M
$38K ﹤0.01%
2,171
-1,614
-43% -$27.1K
INFU icon
6505
InfuSystem Holdings
INFU
$249M
$38K ﹤0.01%
4,500
-1,298
-22% -$9.56K
KEQU icon
6506
Kewaunee Scientific
KEQU
$106M
$38K ﹤0.01%
2,850
+222
+8% +$3.47K
MAG
6507
DELISTED
MAG Silver
MAG
$38K ﹤0.01%
3,190
NOBL icon
6508
PUT
ProShares S&P 500 Dividend Aristocrats ETF
NOBL
$12B
$38K ﹤0.01%
1,000
PRNT icon
6509
The 3D Printing ETF
PRNT
$65M
$38K ﹤0.01%
1,692
-906
-35% -$19.3K
XP icon
6510
XP
XP
$8.39B
$38K ﹤0.01%
+988
New +$37.1K
TRAW icon
6511
Traws Pharma
TRAW
$8.1M
$38K ﹤0.01%
264
+252
+2,100% +$47.1K
ISZE
6512
DELISTED
iShares MSCI Intl Size Factor ETF
ISZE
$38K ﹤0.01%
1,354
+1,000
+282% +$27.2K
CNTG
6513
DELISTED
Centogene N.V. Common Shares
CNTG
$38K ﹤0.01%
+3,736
New +$44.5K
USEQ
6514
DELISTED
Invesco Russell 1000 Enhanced Equal Weight ETF
USEQ
$38K ﹤0.01%
1,255
-100
-7% -$2.92K
DFVS
6515
DELISTED
iPath US Treasury 5-year Bear ETN
DFVS
$38K ﹤0.01%
1,400
+1,100
+367% +$28.7K
JHMS
6516
DELISTED
John Hancock Multifactor Consumer Staples ETF
JHMS
$38K ﹤0.01%
1,264
+970
+330% +$28.4K
MLPC
6517
DELISTED
C-Tracks ETNs based on Performance of the Miller/Howard MLP Fundamental Index
MLPC
$38K ﹤0.01%
3,033
+300
+11% +$3.64K
IBRX icon
6518
ImmunityBio
IBRX
$8.1B
$37K ﹤0.01%
9,801
-4,253
-30% -$7.24K
KEN icon
6519
Kenon Holdings
KEN
$3.45B
$37K ﹤0.01%
1,754
+262
+18% +$5.58K
PAPR icon
6520
Innovator US Equity Power Buffer ETF April
PAPR
$961M
$37K ﹤0.01%
+1,404
New +$36.6K
UBOT icon
6521
Direxion Daily Robotics Artificial Intelligence & Automation Index Bull 2X ETF
UBOT
$27M
$37K ﹤0.01%
1,421
+347
+32% +$8.27K
ACER
6522
DELISTED
Acer Therapeutics Inc
ACER
$37K ﹤0.01%
9,180
+5,350
+140% +$18.2K
UBP
6523
DELISTED
Urstadt Biddle Properties Inc.
UBP
$37K ﹤0.01%
1,854
-83
-4% -$1.57K
NKG
6524
DELISTED
Nuveen Georgia Quality Municipal Income Fund
NKG
$37K ﹤0.01%
2,925
-3,664
-56% -$45.6K
AMCA
6525
DELISTED
iShares Russell 1000 Pure U.S. Revenue ETF
AMCA
$37K ﹤0.01%
1,215
+1,210
+24,200% +$35.8K

Similar funds

UBS Group's Q4 2019 Portfolio in Review

As of Q4 2019, UBS Group held 8,864 positions worth $287B, up 11% from $260B the previous quarter. Its ten largest holdings account for 13% of the portfolio.

UBS Group's Q4 2019 filing shows 808 new, 4,306 increased, 2,684 reduced and 688 closed positions. Its largest new stake was Bristol-Myers Squibb Company Contingent Value Rights: 5,302,748 shares worth $16M. The largest sale was State Street SPDR S&P 500 ETF Trust, an estimated $1.3B.

By sector, the portfolio is most concentrated in Technology at 9.8% of assets, up from 9.5% a quarter earlier, followed by Financials and Healthcare.

  • UBS Group's largest Q4 2019 buy was Bristol-Myers Squibb Company Contingent Value Rights: 5,302,748 shares worth $16M.
  • UBS Group added most to UBS Group in Q4 2019, an estimated $1.48B increase.
  • UBS Group's biggest Q4 2019 reduction was State Street SPDR S&P 500 ETF Trust, cutting an estimated $1.3B.
  • UBS Group fully exited Altaba Inc in Q4 2019, selling an estimated $759M.
  • UBS Group's ten largest holdings make up 13% of its $287B portfolio in Q4 2019.
  • UBS Group opened 808 new positions and closed 688 in Q4 2019.
  • UBS Group's portfolio value rose 11% quarter-over-quarter to $287B.

Based on UBS Group's 13F filing for Q4 2019, filed 14 Feb 2020.